These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7928591)

  • 41. Compounding policies updated in anticipation of federal action.
    J Am Vet Med Assoc; 2013 Aug; 243(3):307-8. PubMed ID: 24024283
    [No Abstract]   [Full Text] [Related]  

  • 42. The compounding controversy: what veterinarians should know to protect themselves and their patients.
    Davidson G
    J Am Anim Hosp Assoc; 2003; 39(1):13-7. PubMed ID: 12549608
    [No Abstract]   [Full Text] [Related]  

  • 43. A step closer to reality: professional flexible labeling for animal drugs.
    Gloyd JS
    J Am Vet Med Assoc; 1996 Feb; 208(4):457-9. PubMed ID: 8603883
    [No Abstract]   [Full Text] [Related]  

  • 44. New Jersey standards affect dispensing of i.v. admixtures.
    Polillo PC; Ferri L
    Am J Hosp Pharm; 1987 Nov; 44(11):2486-7. PubMed ID: 3687980
    [No Abstract]   [Full Text] [Related]  

  • 45. Psychiatric drugs and trends; new regulations on vitamins and minerals.
    Dembicki EL
    J Psychiatr Nurs Ment Health Serv; 1974; 12(2):43-5. PubMed ID: 4362712
    [No Abstract]   [Full Text] [Related]  

  • 46. Flexible labeling, streamlined drug approval advocated at workshop.
    Raef TA
    J Am Vet Med Assoc; 1995 Jul; 207(1):7-9. PubMed ID: 7601697
    [No Abstract]   [Full Text] [Related]  

  • 47. Errors discovered in a manufacturing program.
    Das Gupta V
    Am J Hosp Pharm; 1973 Feb; 30(2):112. PubMed ID: 4690464
    [No Abstract]   [Full Text] [Related]  

  • 48. Drug use guidelines for veterinary practitioners.
    Gloyd JS
    J Am Vet Med Assoc; 1993 May; 202(10):1738-9;discussion 1740-1. PubMed ID: 8514600
    [No Abstract]   [Full Text] [Related]  

  • 49. Issues confronting professional compounding in the 21st century: a student's perspective.
    Levy J
    J Am Vet Med Assoc; 1994 Jul; 205(2):297-8. PubMed ID: 7928607
    [No Abstract]   [Full Text] [Related]  

  • 50. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The health hazard of unlabeled ingredients in pharmaceuticals.
    Brown JL
    Pediatrics; 1984 Mar; 73(3):402-4. PubMed ID: 6701067
    [No Abstract]   [Full Text] [Related]  

  • 52. Current FDA policy on use of human-labeled drugs in animals.
    Teske RH
    J Am Vet Med Assoc; 1993 May; 202(10):1632-3;discussion 1634. PubMed ID: 8514570
    [No Abstract]   [Full Text] [Related]  

  • 53. Potential clinical impact of compounded versus noncompounded intrathecal baclofen.
    Moberg-Wolff E
    Arch Phys Med Rehabil; 2009 Nov; 90(11):1815-20. PubMed ID: 19887203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response to comments on the proposed model of a professional drug label.
    Martinez MN; Brown SA; Copeland DD; Haibel GK; Koritz GD; Riddell MG; Riviere JE; Rollins LD
    J Am Vet Med Assoc; 1996 Dec; 209(12):2068-70. PubMed ID: 8960188
    [No Abstract]   [Full Text] [Related]  

  • 55. Some compounding may be allowed, even if still illegal.
    J Am Vet Med Assoc; 2015 Jul; 247(1):25. PubMed ID: 26285314
    [No Abstract]   [Full Text] [Related]  

  • 56. Professional drug labeling.
    Terry M
    J Am Vet Med Assoc; 1993 May; 202(10):1711-2;discussion 1713-7. PubMed ID: 8514591
    [No Abstract]   [Full Text] [Related]  

  • 57. Extra-label rules: the final outcome.
    Curry-Galvin E
    J Am Vet Med Assoc; 1997 Jan; 210(1):10-2. PubMed ID: 8977639
    [No Abstract]   [Full Text] [Related]  

  • 58. The changing face of vaccine labels.
    O'Rourke K
    J Am Vet Med Assoc; 2003 Sep; 223(6):752-3. PubMed ID: 14507078
    [No Abstract]   [Full Text] [Related]  

  • 59. Impact of compounding on free trade agreements.
    Crawford LM
    J Am Vet Med Assoc; 1994 Jul; 205(2):288-9. PubMed ID: 7928602
    [No Abstract]   [Full Text] [Related]  

  • 60. Is compounding compatible with quality assurance programs?
    Lautner B
    J Am Vet Med Assoc; 1994 Jul; 205(2):276-9. PubMed ID: 7928597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.